Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 246 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Calcification Clear all

Conditions: Osteoblast, Adipocytes, Bone Density, Osteocalcin, Adiponectin, Mesenchymal Stem Cells
Interventions: Pioglitazone, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: HIV Infections
Interventions: Alendronate, Calcium carbonate, Vitamin D; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 25 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 28
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 17 more

Conditions: Hip Fracture
Interventions: Exercise Plus Program; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 65 Years and older · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2005
U.S. locations: 3
States / cities: Baltimore, Maryland • Randallstown, Maryland • Towson, Maryland

Conditions: Juvenile Rheumatoid Arthritis
Interventions: Calcium carbonate; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Years to 18 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2001
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Prostate Cancer
Interventions: zoledronic acid; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 44
States / cities: Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 38 more

Conditions: Survivors of Bone Marrow Transplant, Autologous and Allogeneic
Interventions: Not listed
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 8 Years to 30 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis
Interventions: Hormone replacement therapy, Strength training; Drug · Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1995 – 2001
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Bone Cancer
Interventions: Tissue Sample; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Juvenile Rheumatoid Arthritis
Interventions: Cholecalciferol, Calcium, Calcium and cholecalciferol, Placebo; Dietary Supplement · Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 3 Years to 15 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2002
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Mild Autonomous Cortisol Secretion (MACS)
Interventions: Osilodrostat (Isturisa); Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: End Stage Renal Disease, Kidney Transplantation, Bone Loss, Fractures, Vascular Calcifications
Interventions: Vitamin D3, Calcitriol, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteopenia
Interventions: Tai Chi, Standard Care; Other
Lead sponsor: Harvard University Faculty of Medicine; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Uterine Cervical Neoplasms
Interventions: Zoledronic acid; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cervical Cancer, Endometrial Cancer, Vaginal Cancer
Interventions: CT or MRI + Blood Test; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Female only
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bone Health, Osteoporosis
Interventions: Yoga Group; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 35 Years to 50 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Norman, Oklahoma

Conditions: Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
Interventions: Denosumab, Placebo; Biological
Lead sponsor: Amgen; Industry
Eligibility: 30 Years to 120 Years · Male only
Enrollment: 769 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 52
States / cities: Anaheim, California • Laguna Hills, California • Murrieta, California + 45 more

Conditions: Breast Cancer, Osteoporosis
Interventions: biologic sample preservation procedure, dual x-ray absorptometry; Other · Procedure
Lead sponsor: NCIC Clinical Trials Group; Network
Eligibility: 35 Years and older · Female only
Enrollment: 238 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 13
States / cities: Torrance, California • Washington D.C., District of Columbia • Scarborough, Maine + 9 more

Conditions: Phenylketonurias
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Low Bone Mass, Osteoporosis, Postmenopausal
Interventions: DHEA, Placebo, Exercise; Other · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 55 Years to 85 Years · Female only
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypopituitarism
Interventions: Arimidex (Anastrozole), Placebo, Growth Hormone; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 11 Years to 18 Years · Male only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2010
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Knee Arthropathy
Interventions: Cement, Cementless, Manual Surgery, Robotic Surgery; Procedure · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Weight Loss, Time Restricted Feeding, Bone Loss
Interventions: Time Restricted Eating (TRE), Calorie Restriction; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years to 79 Years · Female only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Osteoporosis, Osteopenia
Interventions: Calcium carbonate, Calcium Phosphate; Drug
Lead sponsor: Creighton University; Other
Eligibility: 60 Years to 85 Years · Female only
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Epilepsy, Bone Loss, Osteoporosis, Fractures
Interventions: Risedronate, Placebo + Calcium and Vitamin D; Drug
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Effect of Thiazolidinediones on Human Bone

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women

Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Musculoskeletal Outcomes After Bone Marrow Transplant

Bone Estrogen Strength Training

Retrospective Study of the Biomechanical Properties of Large Allografts

Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Bone Mass and Strength After Kidney Transplantation

Tai Chi for Osteopenic Women

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Pelvic Fractures and Radiation Therapy for Cervical Cancer

Effects of Yoga on Bone Metabolism in Premenopausal Women

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Bone Mineral Density in Adults With Hyperphenylalaninemia

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty

TRE: Microbiome, Metabolic Health and Bone

Adding Phosphorus to Osteoporosis Drug Treatment

Antiepileptic Drugs and Osteoporotic Prevention Trial